Emphasis on Product Type (Drugs {Opioids, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Anticonvulsants, Antidepressants, Others}, Devices {Neurostimulation Device [SCS, TENS, Others], Ablation Devices, Radiofrequency Ablation Devices, and Cryoablation Devices}); Application (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer Pain, Migraine, Fibromyalgia, Others); End-Users (Hospitals & Clinics, Nursing Homes, Research Centers, Others); Region/Country
Chronic pain has a significant impact on patient health and on the resource costs of healthcare providers. Ensuring chronic diseases are appropriately diagnosed and treated is essential in order to prevent unnecessary suffering for patients. Proper chronic pain treatment prevents infection and long-term complications and also helps speed up the healing process. According to the center for disease (CDC), control 6 out of 10 American people are diagnosed with at least one chronic disease like heart disease, stroke, or cancer. These and other chronic diseases are major causes of death in the U.S., for instance, according to the CDC, the prevalence of chronic pain and high-impact chronic pain in the U.S., an estimated 20.0% (50.0 million) of U.S. adults had chronic pain and 8.0% of U.S. adults (19.6 million) had high-impact chronic pain, with higher prevalences of both chronic pain and high-impact chronic pain reported among women, older, adults.
The demand for chronic pain treatment products is increasing owing to an increasing geriatric population, and the rising prevalence of chronic diseases across the globe. Furthermore, the increasing incidence of osteoarthritis, fibromyalgia, trauma, and back pain due to a sedentary lifestyle is one of the leading factors contributing to market growth. Thus, the market is expected to witness a CAGR of ~7% during the forecast period.
Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Medtronic Plc., Boston Scientific Corporation, Novartis AG, Johnson & Johnson, AstraZeneca PLC, Sanofi S.A., and Becton, Dickinson and Company are some of the prominent players operating in the market.
Insights Presented in the Report
“Amongst By Product, Drug category holds the major share”
Based on product type, the market is segmented into drugs and devices. In 2020, the drug category accounted for a larger share market share owing to the rising geriatric population across the globe coupled with the increasing prevalence of different types of chronic diseases such as severe headaches, and lower back pain. Furthermore, market growth is driven by the increasing spending on chronic diseases, technological advancements, and the growing prevalence of chronic diseases & post-surgical complications.
“Amongst By Application, chronic wounds segment holds the major share”
Based on application, the market has been bifurcated into neuropathic pain, arthritis pain, chronic back pain, cancer pain, migraine, fibromyalgia, and others. In 2020, the cancer pain segment held the largest share and is anticipated to witness a considerable growth rate over the forecast period. The increasing number of geriatric populations, along with the rising prevalence of cancer is expected to drive the segment growth. For instance, according to the American Society of Clinical Oncology, lung cancer is the second most common cancer and approximately 235,760 adults (119,100 men and 116,660 women) in the United States will be diagnosed with lung cancer by the end of 2021.
“Amongst End-Users, hospital & clinics category holds the major share”
Based on end-users, the global market is categorized into hospitals & clinics, nursing homes, and research centers. In 2020, the hospitals and clinics end-user category held a significant share in the market and is expected to grow with a strong CAGR during the forecast period (2021-2027F). The growth of this category is due to rising awareness, technological advancement, the large number of treatment procedures conducted in hospitals, and the easy availability of reimbursements. In addition, the number of new cancer cases in 2020 (In 2020, there will be an estimated 1.8 million new cancer cases diagnosed in the U.S.).
“North America represents one of the largest markets of Chronic Pain market”
For a better understanding of the market, the report provides a detailed analysis of major regions and countries including By region North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Spain, Italy, Rest of Europe); Asia-Pacific (China, Japan, India, Rest of Asia-Pacific) and Rest of World). In 2020, North America accounted for the largest market share in 2020. The large share of this region’s market can be attributed to the growing prevalence of chronic conditions resulting in chronic, and post-surgical complications. In addition, the surging number of cancer cases, presence of strong healthcare infrastructure and industry players, increasing FDA approvals along with strategic alliances and high investment in research and development activities are some other crucial factors proliferating the North American chronic pain treatment market.
Reasons to buy this report:
Customization Options:
The chronic pain treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Chronic Pain Treatment Covid-19 Impact
6. Chronic Pain Treatment Revenue, 2019-2027f
7. Market Insights By Product Type
8. Market Insights By Application
9. Market Insights By End-user
10. Market Insights By Region
11. Chronic Pain Treatment Market Dynamics
12. Chronic Pain Treatment Market Opportunities
13. Chronic Pain Treatment Market Trends
14. Legal & Regulatory Framework
15. Demand And Supply-side Analysis
16. Value Chain Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Chronic Pain Treatment Market Analysis (2021-2027)
Analyzing the historical market, estimation of the current market, and forecasting the future market of the chronic pain treatment market were the three major steps undertaken to create and analyze the adoption of chronic pain treatment in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the chronic pain treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Seek More Details About Research Methodology
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the chronic pain treatment through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the chronic pain treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as product, application, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of chronic pain treatment across the globe.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of chronic pain treatment. Further, we conducted factor analysis using dependent and independent variables such as the rising target disease population. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the chronic pain treatment sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Chronic Pain market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Chronic Pain market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, application, and end-user of the chronic pain treatment.
The main objective of the Chronic Pain Market Study
The current & future market trends of Chronic Pain were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Deep dive regional level analysis of the industry
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
